people News newsbot.ch

Wirtschaft »

FDA approves Roche’s Rozlytrek (entrectinib) for people with ROS1-positive, metastatic non-small cell lung cancer and NTRK gene fusion-positive solid tumours

2019-08-16 16:40:40


Wirtschaft »

Roche’s Tecentriq plus platinum-based chemotherapy reduced the risk of disease worsening or death in people with previously untreated advanced bladder cancer

2019-08-05 05:40:23


Wirtschaft »

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

2019-07-31 09:24:45


Wirtschaft »

Roche receives CHMP positive opinion for new Tecentriq-based combination therapy as an initial treatment for most common form of advanced lung cancer

2019-07-26 11:20:11


Wirtschaft »

CHMP recommends EU approval of Roche’s Tecentriq in combination with chemotherapy as an initial treatment of adults with extensive-stage small cell lung cancer

2019-07-26 11:20:11


Wirtschaft »

Roche presents a broad range of data for Hemlibra demonstrating continued benefits for people with haemophilia A at the ISTH 2019 Congress

Roche presents a broad range of data for Hemlibra demonstrating continued benefits for people with haemophilia A at the ISTH 2019 Congress

2019-07-09 09:20:15


Wirtschaft »

Novartis führt in der Schweiz bezahlte Elternauszeit von 18 Wochen ein

2019-07-05 09:20:48


Wirtschaft »

CHMP recommends EU approval of Roche’s Tecentriq in combination with Abraxane as an initial treatment for people with PD-L1-positive, metastatic triple-negative breast cancer

2019-06-28 12:20:05


Wirtschaft »

Japan becomes the first country to approve Roche’s personalised medicine Rozlytrek

2019-06-18 06:20:04


Wirtschaft »

FDA grants Roche’s Polivy accelerated approval for people with previously treated aggressive lymphoma

2019-06-11 14:40:06


Wirtschaft »

Roche and Spark Therapeutics, Inc. receive Request for Additional Information from FTC under Hart-Scott-Rodino Act and announce extension of tender offer for shares of Spark Therapeutics, Inc.

2019-06-10 12:40:00


Wirtschaft »

Pivotal phase III CLL14 results for Venclexta/Venclyxto in combination with Gazyva/Gazyvaro for chronic lymphocytic leukaemia presented at ASCO 2019 and published in the New England Journal of Medicine

2019-06-04 19:20:00


Wirtschaft »

Roche presents data from across its breast cancer portfolio at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

2019-06-03 06:20:42


Wirtschaft »

Roche’s Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer shows positive data in those with liver metastases

2019-06-02 12:20:56


Wirtschaft »

Roche and GE Healthcare launch NAVIFY Tumor Board with medical imaging capabilities to enable more personalised treatment decisions in cancer care

2019-05-31 12:20:01


Wirtschaft »

Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia

Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia

2019-05-16 08:40:14


Wirtschaft »

Roche’s personalised medicine entrectinib shrank tumours harbouring NTRK, ROS1 or ALK gene fusions in children and adolescents

2019-05-16 08:40:14


Wirtschaft »

New Roche test aids clinicians in accelerating tuberculosis diagnosis and treatment by detecting antimicrobial resistance within the world’s leading cause of infectious disease deaths

2019-05-14 05:20:02


Wirtschaft »

Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Report Forms under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.

2019-05-14 05:20:02


Wirtschaft »

Roche to present new data highlighting comprehensive approach to cancer care at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

2019-05-10 05:20:01



Suchresultate als RSS-Feed